Open access
Open access
Powered by Google Translator Translator

Internal Medicine

Genomic evidence for reinfection with SARS-CoV-2: A case study

14 Oct, 2020 | 09:39h | UTC

Genomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases

Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get reinfected with Covid-19 but still have immunity. Let’s explain. – Vox AND A 25-Year-Old Nevada Man Got COVID-19 Twice. Here’s What We Know—and Don’t Know—About Reinfection – TIME

Related: Dutch woman dies after catching Covid-19 twice, the first reported reinfection death – CNN

 


Updated NIH COVID-19 Treatment Guidelines

14 Oct, 2020 | 09:41h | UTC

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health

See also: What’s New in the Guidelines

 


COVID-19 and cancer: Current challenges and perspectives

14 Oct, 2020 | 09:35h | UTC

COVID-19 and Cancer: Current Challenges and Perspectives – Cancer Cell

Commentary: Study offers global review of impact of COVID-19 on cancer treatment and research – Dana-Farber Cancer Institute

 


Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

14 Oct, 2020 | 09:31h | UTC

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT

News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials

Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – Health Policy Watch AND Johnson & Johnson pauses Covid-19 vaccine trial after ‘unexplained illness’ – CNN

 


Non-respiratory presentations of COVID-19, a clinical review

14 Oct, 2020 | 09:33h | UTC

Non-respiratory presentations of COVID-19, a clinical review – The American Journal of Emergency Medicine

 


Monoclonal antibody trial halted for safety concern

14 Oct, 2020 | 09:30h | UTC

Monoclonal Antibody Trial Halted for Safety Concern – Brief19

Related: Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern – Reuters

 


COVID-19 will probably become endemic – here’s what that means

14 Oct, 2020 | 09:27h | UTC

COVID-19 will probably become endemic – here’s what that means – The Conversation

 


Case report: Sudden irreversible hearing loss post COVID-19

14 Oct, 2020 | 09:24h | UTC

Sudden irreversible hearing loss post COVID-19 – BMJ Case Reports

Commentaries: Coronavirus: Patient has sudden permanent hearing loss – BBC AND First reported UK case of sudden permanent hearing loss linked to COVID-19 – BMJ

 

Commentary on Twitter

 


Meta-analysis: Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension

14 Oct, 2020 | 09:20h | UTC

Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension – Journal of the American Heart Association

 

Commentary on Twitter

 


Meta-analysis: Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery

14 Oct, 2020 | 09:16h | UTC

Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis – JAMA Internal Medicine (free for a limited period)

 

Commentary on Twitter


 


Meta-analysis: Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness

14 Oct, 2020 | 09:18h | UTC

Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness: A Systematic Review and Meta-analysis – JAMA

Editorial: Palliative Care for Patients With Noncancer Illnesses

 

Commentary on Twitter

 


Opinion piece by Dr. John P.A. Ioannidis: Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic

13 Oct, 2020 | 01:15h | UTC

Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic – European Journal of Clinical Investigation

 


Pursuing COVID ‘herd immunity’ without a vaccine could be dangerous & unethical, WHO warns

13 Oct, 2020 | 01:16h | UTC

Pursuing COVID ‘Herd Immunity’ Without A Vaccine Could Be Dangerous & Unethical, WHO Warns – As World Reaches Record Peaks For New Infections – Health Policy Watch

 


Review: Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19

13 Oct, 2020 | 01:12h | UTC

Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19 – Pharmacotherapy

 


[Preprint] Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics

13 Oct, 2020 | 01:08h | UTC

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics – medRxiv

 

Commentary on Twitter

 


‘Long Covid’: Why are some people not recovering?

13 Oct, 2020 | 01:03h | UTC

‘Long Covid’: Why are some people not recovering? – BBC

 


Cohort study: ‘COVID-19 free’ hospital areas linked to improved outcomes in elective cancer surgery

12 Oct, 2020 | 00:48h | UTC

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study – Journal of Clinical Oncology

Commentary: ‘COVID-19 free’ hospital areas could save lives after surgery, global study finds – University of Birmingham

 


Study: Three quarters of people with SARS-CoV-2 infection were asymptomatic the day they took the test

12 Oct, 2020 | 00:46h | UTC

Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey Data – Clinical Epidemiology

Commentaries: Covid: more than 80% of positive UK cases in study had no core symptoms – The Guardian AND Symptoms of COVID-19 are a poor marker of infection, new UK population study shows – Taylor & Francis Group AND Expert reaction to analysis of asymptomatic SARS-CoV-2 infection from English Household Survey data – Science Media Centre

 


Review: Characteristics of SARS-CoV-2 and COVID-19

12 Oct, 2020 | 00:49h | UTC

Characteristics of SARS-CoV-2 and COVID-19 – Nature Reviews Microbiology

 

Commentary on Twitter

 


Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset

12 Oct, 2020 | 00:44h | UTC

Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset – Clinical Microbiology and Infection

Commentary: Even Mild Covid-19 Infections Can Make People Sick for Months – Bloomberg

 

Commentary on Twitter

 


Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

12 Oct, 2020 | 00:34h | UTC

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study – Intensive Care Medicine

 

Commentary on Twitter

 


Esophageal emergencies: Another important cause of acute chest pain

12 Oct, 2020 | 00:30h | UTC

Esophageal emergencies: another important cause of acute chest pain – Insights into Imaging

 


RECOVERY trial: Effect of hydroxychloroquine in hospitalized patients with Covid-19

9 Oct, 2020 | 09:15h | UTC

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 – New England Journal of Medicine

 


Less is more: Critically ill status is not a carte blanche for unlimited antibiotic use

12 Oct, 2020 | 00:32h | UTC

Less is more: critically ill status is not a carte blanche for unlimited antibiotic use – Intensive Care Medicine

 


AHA Scientific Statement: Assessing and addressing cardiovascular health in LGBTQ adults

12 Oct, 2020 | 00:29h | UTC

Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association – Circulation

News Release: Discrimination contributes to poorer heart health for LGBTQ adults – American Heart Association

Commentary: Improving the Cardiovascular Health of the LGBTQ Community: An Urgent Call to Action

Top Things to Know: Assessing and Addressing Cardiovascular Health in LGBTQ Adults

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.